Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients.

@article{Hawkins2005ComparisonON,
  title={Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients.},
  author={Trevor N Hawkins and Cindy Geist and Ben Young and Andrea Giblin and Renee C Mercier and Karla A Thornton and Richard Haubrich},
  journal={HIV clinical trials},
  year={2005},
  volume={6 4},
  pages={187-96}
}
PURPOSE To compare the extent of neuropsychiatric disturbances in two similar groups of HIV-infected patients treated for >4 weeks with either efavirenz (EFV) or protease inhibitors (PIs) as part of their antiretroviral therapy (ART). METHOD A cross-sectional, questionnaire-based cohort of HIV patients who received two nucleoside reverse transcriptase inhibitors combined with either EFV (n = 75) or one or more PIs (n = 77) for at least 4 weeks and were tolerating therapy. The extent of… CONTINUE READING